🇺🇸 FDA
Patent

US 8921340

Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions

granted A61KA61K31/122A61K31/26

Quick answer

US patent 8921340 (Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/122, A61K31/26, A61K31/277, A61K31/4164